75 related articles for article (PubMed ID: 7773608)
1. Carbamylation decreases the cytotoxicity but not the drug-carrier properties of polylysines.
Ekrami HM; Shen WC
J Drug Target; 1995; 2(6):469-75. PubMed ID: 7773608
[TBL] [Abstract][Full Text] [Related]
2. Inducing a change in the pharmacokinetics and biodistribution of poly-L-lysine in rats by complexation with heparin.
Johnston TP; Kuchimanchi KR; Alur H; Chittchang M; Mitra AK
J Pharm Pharmacol; 2003 Aug; 55(8):1083-90. PubMed ID: 12956897
[TBL] [Abstract][Full Text] [Related]
3. Disposition characteristics of glycosylated poly(amino acids) as liver cell-specific drug carrier.
Akamatsu K; Imai M; Yamasaki Y; Nishikawa M; Takakura Y; Hashida M
J Drug Target; 1998; 6(3):229-39. PubMed ID: 9888309
[TBL] [Abstract][Full Text] [Related]
4. Disposition of positively charged Bowman-Birk protease inhibitor conjugates in mice: influence of protein conjugate charge density and size on lung targeting.
Ekrami H; Kennedy AR; Shen WC
J Pharm Sci; 1995 Apr; 84(4):456-61. PubMed ID: 7629736
[TBL] [Abstract][Full Text] [Related]
5. Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier.
Choi YH; Liu F; Park JS; Kim SW
Bioconjug Chem; 1998; 9(6):708-18. PubMed ID: 9815164
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties.
Nishikawa M; Takemura S; Takakura Y; Hashida M
J Pharmacol Exp Ther; 1998 Oct; 287(1):408-15. PubMed ID: 9765363
[TBL] [Abstract][Full Text] [Related]
7. In vitro cytotoxicity, chemotactic effect, and cellular uptake of branched polypeptides with poly[L-lys] backbone by J774 murine macrophage cell line.
Szabó R; Mezö G; Pállinger E; Kovács P; Köhidai L; Bösze S; Hudecz F
Bioconjug Chem; 2008 May; 19(5):1078-86. PubMed ID: 18429626
[TBL] [Abstract][Full Text] [Related]
8. Conjugation of 5-fluoro-2'-deoxyuridine with lactosaminated poly-l-lysine to reduce extrahepatic toxicity in the treatment of hepatocarcinomas.
Di Stefano G; Busi C; Derenzini M; Trerè D; Fiume L
Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):173-7. PubMed ID: 9675653
[TBL] [Abstract][Full Text] [Related]
9. Characterization of novel kidney-specific delivery system using an alkylglucoside vector.
Shirota K; Kato Y; Suzuki K; Sugiyama Y
J Pharmacol Exp Ther; 2001 Nov; 299(2):459-67. PubMed ID: 11602655
[TBL] [Abstract][Full Text] [Related]
10. Dendritic poly(L-lysine)-b-Poly(L-lactide)-b-dendritic poly(L-lysine) amphiphilic gene delivery vectors: roles of PLL dendritic generation and enhanced transgene efficacies via termini modification.
Li Y; Zhu Y; Xia K; Sheng R; Jia L; Hou X; Xu Y; Cao A
Biomacromolecules; 2009 Aug; 10(8):2284-93. PubMed ID: 19586045
[TBL] [Abstract][Full Text] [Related]
11. A dimethylmaleic acid-melittin-polylysine conjugate with reduced toxicity, pH-triggered endosomolytic activity and enhanced gene transfer potential.
Meyer M; Zintchenko A; Ogris M; Wagner E
J Gene Med; 2007 Sep; 9(9):797-805. PubMed ID: 17628028
[TBL] [Abstract][Full Text] [Related]
12. An adduct of cis-diamminedichloroplatinum(II) and poly(ethylene glycol)poly(L-lysine)-succinate: synthesis and cytotoxic properties.
Bogdanov AA; Martin C; Bogdanova AV; Brady TJ; Weissleder R
Bioconjug Chem; 1996; 7(1):144-9. PubMed ID: 8742003
[TBL] [Abstract][Full Text] [Related]
13. Novel symmetric amphiphilic dendritic poly(L-lysine)-b-poly(L-lactide)-b-dendritic poly(L-lysine) with high plasmid DNA binding affinity as a biodegradable gene carrier.
Li Y; Cui L; Li Q; Jia L; Xu Y; Fang Q; Cao A
Biomacromolecules; 2007 May; 8(5):1409-16. PubMed ID: 17458996
[TBL] [Abstract][Full Text] [Related]
14. Regiospecific gamma-conjugation of methotrexate to poly(L-lysine). Chemical and biological studies.
Rosowsky A; Forsch RA; Galivan J; Susten SS; Freisheim JH
Mol Pharmacol; 1985 Jan; 27(1):141-7. PubMed ID: 3965926
[TBL] [Abstract][Full Text] [Related]
15. (211)At-labeled and biotinylated effector molecules for pretargeted radioimmunotherapy using poly-L- and poly-D-Lysine as multicarriers.
Lindegren S; Karlsson B; Jacobsson L; Andersson H; Hultborn R; Skarnemark G
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3873S-9S. PubMed ID: 14506185
[TBL] [Abstract][Full Text] [Related]
16. Preferential binding of radiolabeled poly-L-lysines to C6 and U87 MG glioblastomas compared with endothelial cells in vitro.
Kornguth SE; Kalinke T; Robins HI; Cohen JD; Turski P
Cancer Res; 1989 Nov; 49(22):6390-5. PubMed ID: 2804985
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and in vivo gene transfer of plasmid DNA complexed with mannosylated poly(L-lysine) in mice.
Nishikawa M; Takemura S; Yamashita F; Takakura Y; Meijer DK; Hashida M; Swart PJ
J Drug Target; 2000; 8(1):29-38. PubMed ID: 10761643
[TBL] [Abstract][Full Text] [Related]
18. Cationic poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats.
Boyd BJ; Kaminskas LM; Karellas P; Krippner G; Lessene R; Porter CJ
Mol Pharm; 2006; 3(5):614-27. PubMed ID: 17009860
[TBL] [Abstract][Full Text] [Related]
19. Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(d,l-lactide-co-glycolide): effects of polymer structure on cytotoxicity.
Unger F; Wittmar M; Kissel T
Biomaterials; 2007 Mar; 28(9):1610-9. PubMed ID: 17196250
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, and gene delivery of poly-L-lysine octa(3-aminopropyl)silsesquioxane dendrimers: nanoglobular drug carriers with precisely defined molecular architectures.
Kaneshiro TL; Wang X; Lu ZR
Mol Pharm; 2007; 4(5):759-68. PubMed ID: 17705440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
